Is RXST or STAA more undervalued in 2026?

CirclFi compares RxSight, Inc. (RXST) and STAAR Surgical Company (STAA) using 13 institutional-grade valuation models. RXST has a Quality of Company score of 6.8/10 while STAA scores 7.2/10.

Which is a better buy — RXST or STAA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RXST and STAA valuations compare?

RXST at $5.33 and STAA at $29.89 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RXST vs STAA Valuation Comparison 2026 — Intrinsic Value Analysis

RXST

Ophthalmic Goods

RxSight, Inc.

Quality

6.8

out of 10

Value Trap

LOW

Price

$5.33

Last close

Models

11/13

Active

STAA

Ophthalmic Goods

STAAR Surgical Company

Quality

7.2

out of 10

Value Trap

SAFE

Price

$29.89

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	RXST Fair Value	RXST Upside	STAA Fair Value	STAA Upside
Bayesian DCF	Intrinsic	$1.82	-65.9%	$3.33	-88.9%
Earnings Power Value	Intrinsic	$6.07	-18.0%	$5.35	-80.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RXST vs STAA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RXST vs STAA — Which Stock Is More Undervalued?

STAA scores higher with a 7.2/10 quality rating vs RXST's 6.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing RxSight, Inc. (RXST) and STAAR Surgical Company (STAA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RXST currently trades at $5.33 with a QOC of 6.8/10, while STAA trades at $29.89 with a QOC of 7.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).